Hubert is our Chief Medical Officer, with ~15 years of experience in the biotech industry. Prior to joining Metacrine, he was Chief Medical and Scientific Officer at Pfenex Inc., overseeing research and development and leading regulatory interactions with US FDA, EMA, Japan’s PMDA and Health Canada. Before that, Hubert held increasingly senior positions at Aileron Therapeutics, Regulus Therapeutics, and Amylin Pharmaceuticals, responsible for translational medicine and clinical development in metabolic disorders, inflammation/fibrosis, hepatitis C and oncology. Prior to starting his biotech career at Amgen, Hubert was Staff Research Investigator at the Gladstone Institute of Cardiovascular Disease, conducting basic research in diabetes and lipid metabolism. Hubert trained in Endocrinology at the University of California, San Francisco and Internal Medicine at the Massachusetts General Hospital. He received his M.D. from Columbia University and B.A.S. in political sciences and biology from Stanford University.